Quanterix (NASDAQ:QTRX) Stock, Quote.Headers.trade-ideas

Quanterix

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

nike shutter2

News

Downgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

PCAR

QTRX

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Bangkok,thailand,-,January,28,2015:,Visa,Credit,Cards,On,Leather,Board.

Price Target

ABNB

ATRC

SBUX

TMUS

WRBY

ZYXI

Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

GoldmanSachs.Shutterstock

AKYA

ARTV

LUNR

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday

Quanterix Corp

Press Releases

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

Penny Stocks

Small Cap

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - BRDG, AKYA, CKPT, QTRX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Quanterix Releases Financial Results for the First Quarter of 2025

BRDG

CKPT

RKDA

Akoya Biosciences

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Fortrea Holdings

Harvard Bioscience

Standard BioTools

Lifecore Biomedical

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Canaccord Genuity

Leerink Partners

Scotiabank

TD Cowen

Goldman Sachs

Comments

Quanterix

Quanterix (NASDAQ:QTRX) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell